Arcus Biosciences prices $250M public offering at $17.50 per share
FROM THE WIRE · SEEKINGALPHA.COM
* Arcus Biosciences (RCUS [https://seekingalpha.com/symbol/RCUS]) stock price slipped about 6% on Thursday pre-market hours as the company priced [https://seekingalpha.com/pr/20695590-arcus-biosciences-announces-pricing-of-250-million-public-offering-of-common-stock] its public…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishA share offering of this size dilutes existing shareholders and typically weighs on the stock in the short term.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Arcus Biosciences priced an public offering of $250 million at $17.50 per share.
- 02The offering covers 14,285,715 common shares and is expected to close on October 23.
- 03The underwriters have a 30-day option to buy up to 2.14 million additional shares.
- 04The stock slipped about 6% in Thursday pre-market trading.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets